Related Experiment Video

Updated: May 14, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling

Alyson K Freeman1, Daniel A Ritt, Deborah K Morrison

  • 1Laboratory of Cell and Developmental Signaling, National Cancer Institute at Frederick, Frederick, MD 21702, USA.

Molecular Cell
|January 29, 2013
PubMed

Insights

Raf kinase dimerization is crucial for Ras-Raf-MEK-ERK pathway signaling and disease-associated mutants, but not for highly active B-Raf. Targeting the dimer interface offers a therapeutic strategy.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Cancer research

Background:

  • Raf kinases are key components of the Ras-Raf-MEK-ERK signaling pathway.
  • Activating mutations in this pathway are linked to various cancers and developmental disorders.
  • Raf dimerization is known to occur but its functional importance remains unclear.

Purpose of the Study:

  • To investigate the functional significance of Raf dimerization in pathway activation.
  • To determine if dimerization is essential for disease-associated Raf mutants.
  • To explore the therapeutic potential of targeting the Raf dimer interface.

Main Methods:

  • Utilized mutational analysis to probe Raf kinase function.
  • Employed a peptide inhibitor to disrupt Raf dimerization.
  • Assessed the impact of dimerization disruption on Raf signaling and biological activity.

Main Results:

  • Raf dimerization is required for normal Ras-dependent Raf activation.
  • Dimerization is essential for the function of Raf mutants with moderate to low kinase activity.
  • Dimerization is not necessary for highly active B-Raf mutants (e.g., V600E-B-Raf).
  • A dimer interface peptide successfully inhibited Raf signaling when dimerization was required.

Conclusions:

  • Raf dimerization is a critical regulator of Ras-Raf-MEK-ERK pathway signaling.
  • The requirement for dimerization varies with Raf mutant kinase activity.
  • The Raf dimer interface represents a viable therapeutic target for specific Raf-driven conditions.

More Related Videos

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...